Clinical outcomes of 20 Japanese patients with insulinoma treated with diazoxide-Reference-Cited by-同舟云学术

Clinical outcomes of 20 Japanese patients with insulinoma treated with diazoxide

Published:2019 Issue:2 Volume:66 Page:149-155
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Niitsu Yoshihiro¹,Minami Isao¹,Izumiyama Hajime¹,Hashimoto Koshi²,Yoshimoto Takanobu¹,Satou Fuminori³,Tsujino Motoyoshi³,Ota Kazuki⁴,Kudo Atsushi⁵,Tanabe Minoru⁵,Yamada Tetsuya¹,Ogawa Yoshihiro⁶

Affiliation:

1. Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan

2. Department of Preemptive Medicine and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan

3. Department of Endocrinology and Metabolism, Tokyo Metropolitan Tama Medical Center, Tokyo 183-8524, Japan

4. Department of Endocrinology, Yokohama City Minato Red Cross Hospital, Kanagawa 231-8682, Japan

5. Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan

6. Department of Molecular and Cellular Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/66/2/66_EJ18-0353/_pdf

Reference18 articles.

1. 1 Iglesias P, Diez JJ (2014) Management of endocrine disease: a clinical update on tumor-induced hypoglycemia. Eur J Endocrinol 170: R147–R157.

2. 2 Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, et al. (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 103: 153–171.

3. 3 Hansen JB (2006) Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives. Curr Med Chem 13: 361–376.

4. 4 Gill GV, Rauf O, MacFarlane IA (1997) Diazoxide treatment for insulinoma: a national UK survey. Postgrad Med J 73: 640–641.

5. 5 Komatsu Y, Nakamura A, Takihata M, Inoue Y, Yahagi S, et al. (2016) Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia. Endocr J 63: 311–314.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Body Radiation Therapy for Symptomatic Pancreatic Insulinoma: Two-Case Report and Literature Review;Current Oncology;2024-07-22

2. Genotype-histotype-phenotype correlations in hyperinsulinemic hypoglycemia;HISTOL HISTOPATHOL;2024

3. Balancing efficacy and adverse reactions using everolimus in a patient with metastatic malignant insulinoma: Case report;Int. Journal of Clinical Pharmacology and Therapeutics;2024-06-01

4. Current views on the treatment of insulinoma;Problems of Endocrinology;2024-02-28

5. Graph Attention Networks for Drug Combination Discovery: Targeting Pancreatic Cancer Genes with RAIN Protocol;2024-02-28